Insiders · PASG

PASG insider transactions

Passage Bio Inc. (PASG) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PASG

• 17d
  SEC Form 4 filed by Director Sondhi Dolan

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 17d
  SEC Form 4 filed by Director Porter Derrell

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 17d
  SEC Form 4 filed by Director Kassberg Thomas Richard

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 17d
  SEC Form 4 filed by Director Kapadia Sandip

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 17d
  SEC Form 4 filed by Director Gowen Maxine

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 17d
  SEC Form 4 filed by Director Countouriotis Athena

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 81d
  SEC Form 4 filed by Borthwick Kathleen

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 81d
  SEC Form 4 filed by Chou William

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 146d
  PRESIDENT AND CEO Chou William converted options into 10,000 shares and sold $75,159 worth of shares (4,076 units at $18.44), increasing direct ownership by 987% to 6,524 units (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 146d
  CFO Borthwick Kathleen converted options into 5,000 shares and sold $38,022 worth of shares (2,062 units at $18.44), increasing direct ownership by 119% to 5,402 units (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 160d
  SEC Form 4 filed by CFO Borthwick Kathleen

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 160d
  SEC Form 4 filed by PRESIDENT AND CEO Chou William

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 265d
  Large owner Lynx1 Capital Management Lp bought $2,261 worth of shares (325 units at $6.96) and bought $221,474 worth of shares (31,683 units at $6.99) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 318d
  Large owner Lynx1 Capital Management Lp bought $662,488 worth of shares (115,725 units at $5.72) and bought $71,338 worth of shares (13,123 units at $5.44) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 346d
  Large owner Orbimed Advisors Llc sold $197,239 worth of shares (583,657 units at $0.34) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 373d
  SEC Form 4 filed by Director Kapadia Sandip

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 373d
  SEC Form 4 filed by Director Gowen Maxine

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 373d
  SEC Form 4 filed by Director Countouriotis Athena

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 373d
  SEC Form 4 filed by Director Porter Derrell

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 373d
  SEC Form 4 filed by Director Islam Saqib

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 373d
  SEC Form 4 filed by Director Sondhi Dolan

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 373d
  SEC Form 4 filed by Director Kassberg Thomas Richard

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 409d
  Large owner Orbimed Advisors Llc sold $78,731 worth of shares (235,572 units at $0.33) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 416d
  Large owner Orbimed Advisors Llc sold $49,704 worth of shares (149,054 units at $0.33) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 446d
  SEC Form 4 filed by CFO Borthwick Kathleen

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 446d
  SEC Form 4 filed by PRESIDENT AND CEO Chou William

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 446d
  SEC Form 4 filed by GC & CORPORATE SECRETARY Cale Edgar B.

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 480d
  CFO Borthwick Kathleen converted options into 8,000 shares and sold $1,686 worth of shares (3,183 units at $0.53), increasing direct ownership by 13% to 41,283 units (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 509d
  Large owner Orbimed Advisors Llc sold $142,223 worth of shares (223,219 units at $0.64) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 515d
  Large owner Orbimed Advisors Llc sold $103,306 worth of shares (147,024 units at $0.70) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 523d
  Large owner Lynx1 Capital Management Lp bought $241,038 worth of shares (373,645 units at $0.65) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 528d
  Large owner Orbimed Advisors Llc sold $138,193 worth of shares (230,321 units at $0.60) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 543d
  Large owner Orbimed Advisors Llc sold $51,988 worth of shares (62,276 units at $0.83) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 548d
  Large owner Orbimed Advisors Llc sold $77,338 worth of shares (97,103 units at $0.80) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 557d
  Large owner Lynx1 Capital Management Lp bought $146,665 worth of shares (259,998 units at $0.56) and bought $137,855 worth of shares (196,355 units at $0.70) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 613d
  SEC Form 4 filed by GC & CORPORATE SECRETARY Cale Edgar B.

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 613d
  SEC Form 4 filed by Director Kassberg Thomas Richard

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 613d
  SEC Form 3 filed by new insider Kassberg Thomas Richard

  3 - Passage BIO, Inc. (0001787297) (Issuer)
• 622d
  Large owner Orbimed Advisors Llc sold $27,903 worth of shares (39,300 units at $0.71) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 627d
  Large owner Orbimed Advisors Llc sold $146,727 worth of shares (200,131 units at $0.73) (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 667d
  New insider Lynx1 Capital Management Lp claimed ownership of 8,426,955 shares (SEC Form 3)

  3 - Passage BIO, Inc. (0001787297) (Issuer)
• 745d
  SEC Form 4 filed by Countouriotis Athena

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 745d
  SEC Form 4 filed by Gowen Maxine

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 745d
  SEC Form 4 filed by Kapadia Sandip

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 745d
  SEC Form 4 filed by Islam Saqib

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 745d
  SEC Form 4 filed by Sondhi Dolan

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 745d
  SEC Form 4 filed by Porter Derrell

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 810d
  SEC Form 4 filed by Borthwick Kathleen

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 810d
  SEC Form 4 filed by Forman Mark S

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 810d
  SEC Form 4 filed by Chou William

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 810d
  SEC Form 4 filed by Cale Edgar B.

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 845d
  Borthwick Kathleen converted options into 4,000 shares and sold $1,426 worth of shares (1,470 units at $0.97), increasing direct ownership by 10% to 28,466 units (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 845d
  Forman Mark S converted options into 5,000 shares and sold $1,589 worth of shares (1,638 units at $0.97), increasing direct ownership by 7% to 48,631 units (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 886d
  Forman Mark S converted options into 50,000 shares and sold $14,390 worth of shares (15,813 units at $0.91), increasing direct ownership by 308% to 45,269 units (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 886d
  Borthwick Kathleen converted options into 30,000 shares and sold $9,712 worth of shares (10,672 units at $0.91), increasing direct ownership by 292% to 25,936 units (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 886d
  Cale Edgar B. sold $14,390 worth of shares (15,813 units at $0.91) and converted options into 50,000 shares, increasing direct ownership by 290% to 45,995 units (SEC Form 4)

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 1041d
  SEC Form 4: King Simona converted options into 31,250 shares and sold $10,079 worth of shares (11,453 units at $0.88), increasing direct ownership by 472% to 23,994 units

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 1042d
  SEC Form 4 filed by Sondhi Dolan

  4 - Passage BIO, Inc. (0001787297) (Issuer)
• 1042d
  SEC Form 3 filed by new insider Sondhi Dolan

  3 - Passage BIO, Inc. (0001787297) (Issuer)
• 1045d
  SEC Form 4 filed by Borthwick Kathleen

  4 - Passage BIO, Inc. (0001787297) (Issuer)